 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on May 01, 2024 |
| Title |
NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Dec 08, 2023 |
| Last update date |
May 01, 2024 |
| Contact name |
Alessandro Gardini |
| E-mail(s) |
agardini@wistar.org
|
| Phone |
2158983755
|
| Organization name |
The Wistar Institute
|
| Lab |
Gardini Lab
|
| Street address |
3601 Spruce St, Room 230
|
| City |
Philadelphia |
| State/province |
PA |
| ZIP/Postal code |
19104 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (28)
|
| GSM7958835 |
U2OS, pLVX-NAB2-STAT6, control, ATAC, biol rep1 |
| GSM7958836 |
U2OS, pLVX-NAB2-STAT6, control, ATAC, biol rep2 |
| GSM7958837 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, ATAC, biol rep1 |
| GSM7958838 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, ATAC, biol rep2 |
| GSM7959240 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, EGR1, biol rep1 |
| GSM7959241 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, EGR1, biol rep2 |
| GSM7959242 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, FLAG, biol rep1 |
| GSM7959243 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, FLAG, biol rep2 |
| GSM7959244 |
U2OS, pLVX-NAB2-STAT6, control, EGR1, biol rep1 |
| GSM7959245 |
U2OS, pLVX-NAB2-STAT6, control, EGR1, biol rep2 |
| GSM7959247 |
U2OS, pLVX-NAB2-STAT6, control, FLAG, biol rep1 |
| GSM7959248 |
U2OS, pLVX-NAB2-STAT6, control, FLAG, biol rep2 |
| GSM7959569 |
U2OS, pLVX-NAB2-STAT6, 1 day doxycycline, 3' mRNA-seq, biol rep1 |
| GSM7959570 |
U2OS, pLVX-NAB2-STAT6, 1 day doxycycline, 3' mRNA-seq, biol rep2 |
| GSM7959571 |
U2OS, pLVX-NAB2-STAT6, 1 day doxycycline, 3' mRNA-seq, biol rep3 |
| GSM7959572 |
U2OS, pLVX-NAB2-STAT6, 1 day doxycycline, 3' mRNA-seq, biol rep4 |
| GSM7959573 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, 3' mRNA-seq, biol rep1 |
| GSM7959574 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, 3' mRNA-seq, biol rep2 |
| GSM7959575 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, 3' mRNA-seq, biol rep3 |
| GSM7959576 |
U2OS, pLVX-NAB2-STAT6, 2 days doxycycline, 3' mRNA-seq, biol rep4 |
| GSM7959577 |
U2OS, pLVX-NAB2-STAT6, 3 days doxycycline, 3' mRNA-seq, biol rep1 |
| GSM7959578 |
U2OS, pLVX-NAB2-STAT6, 3 days doxycycline, 3' mRNA-seq, biol rep2 |
| GSM7959580 |
U2OS, pLVX-NAB2-STAT6, 3 days doxycycline, 3' mRNA-seq, biol rep3 |
| GSM7959581 |
U2OS, pLVX-NAB2-STAT6, 3 days doxycycline, 3' mRNA-seq, biol rep4 |
| GSM7959582 |
U2OS, pLVX-NAB2-STAT6, control, 3' mRNA-seq, biol rep1 |
| GSM7959583 |
U2OS, pLVX-NAB2-STAT6, control, 3' mRNA-seq, biol rep2 |
| GSM7959584 |
U2OS, pLVX-NAB2-STAT6, control, 3' mRNA-seq, biol rep3 |
| GSM7959585 |
U2OS, pLVX-NAB2-STAT6, control, 3' mRNA-seq, biol rep4 |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE249700 |
NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors (ATAC-Seq) |
| GSE249701 |
NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors (ChIP-Seq) |
| GSE249702 |
NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors (RNA-Seq) |
|
| Relations |
| BioProject |
PRJNA1050208 |
|
|
|
|
 |
Less...
More...